Table 7.
Values of V(prescription) for the planning target volume and differences in V(prescription) values relative to control for each of the 10 study patients, a using varying combinations of regions of interest to drive the deformations in the four‐dimensional (4D) dose calculations
| Patient | Prescription dose (Gy) | V(prescription) values (%) | V(prescription) differences (%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LHCE | LHC | LH | LE | LC | L | LHC– LHCE | LH– LE– LHCE LHCE | LC– LHCE | L– LHCE | ||||||||
| 1 | 54.0 b | 99.89 | 99.86 | 99.86 | 99.97 | 99.96 | 99.96 | 0.00 |
|
|
0.08 | 0.07 | |||||
| 2 | 50.4 | 99.11 | 99.71 | 99.15 | 99.81 | 99.99 | 48.31 | 0.60 | 0.04 0.70 | 0.88 |
|
||||||
| 3 | 45.0 c | 99.00 | 98.99 | 96.14 | 99.11 | 94.04 | 65.67 |
|
|
0.11 |
|
|
|||||
| 4 | 70.0 | 100.00 | 100.00 | 99.67 | 99.84 | 89.33 | 74.35 | 0.00 |
|
|
|
|
|||||
| 5 | 63.0 | 99.36 | 97.13 | 69.93 | 67.83 | 41.75 | 0.00 |
|
|
|
|
|
|||||
| 6 | 40.0 d | 99.63 | 93.51 | 80.33 | 60.79 | 13.36 | 0.00 |
|
|
|
|
|
|||||
| 7 | 63.0 | 97.86 | 96.54 | 91.53 | 96.26 | 88.77 | 54.13 |
|
|
|
|
|
|||||
| 8 | 63.0 | 77.10 | 73.32 | 65.51 | 61.34 | 45.36 | 12.23 |
|
|
|
|
|
|||||
| 9 | 60.0 | 79.32 | 77.91 | 74.69 | 75.76 | 51.85 | 41.31 |
|
|
|
|
|
|||||
| 10 | 50.4 | 96.72 | 89.97 | 69.03 | 75.55 | 67.28 | 18.12 |
|
|
|
|
|
|||||
| RMS deviation | 3.26 | 14.87 | 17.93 | 36.89 | 61.56 | ||||||||||||
| Maximum deviation | 6.75 | 29.43 | 38.84 | 86.27 | 99.63 | ||||||||||||
In 3 cases in which the plan actually delivered a lower dose to the clinical target volume (CTV), the actual dose delivered to the CTV is identified as the prescription dose.
The prescription dose of 60.0 Gy was to be delivered to the gross tumor volume. The prescription to the CTV was 54.0 Gy.
Although the prescription dose was 50.4 Gy, the plan actually delivered 45.0 Gy to the CTV.
Although the prescription dose was 50.0 Gy, the plan actually delivered 40.0 Gy to the CTV.
V(prescription) = fractional volume of planning target volume receiving at least prescription dose; dose calculation driven by deformations of lung, heart, cord, external contour; dose calculation driven by deformations of lung, heart, cord; dose calculation driven by deformations of lung, heart; dose calculation driven by deformations of lung, external contour; dose calculation driven by deformations of lung, cord; dose calculation driven by deformations of lung; RMS = root mean square.